NCT05189483 2024-02-07
Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.
Henan Cancer Hospital
Phase 2 Unknown
Clinical Trials
121 trialsNCT03242382 2024-01-23
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Unknown
NCT06217003 2024-01-22
Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma
The First Affiliated Hospital of Xinxiang Medical College
Phase 2 Unknown
NCT01541709 2024-01-02
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
Asan Medical Center
Phase 2 Unknown
NCT04025931 2023-12-29
Chidamide Combined With Toripalimab in Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05549921 2023-12-27
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT01811394 2023-12-06
ISAC
Heidelberg University
Phase 2 Unknown
NCT06140732 2023-11-20
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Xuanwu Hospital, Beijing
Phase 2 Unknown
NCT06125171 2023-11-09
Tucidinostat Plus Apatinib for Advanced Osteosarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT03742193 2023-11-01
PROACH
Ruijin Hospital
Phase 2 Unknown
NCT03420014 2023-10-10
FIBROSARC US
Philogen S.p.A.
Phase 2 Unknown
NCT05329792 2023-10-06
IntriNSiC
Philogen S.p.A.
Phase 2 Unknown
NCT03890068 2023-08-01
Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05952128 2023-07-19
Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT02365441 2023-07-07
ALT GIST
Australasian Gastro-Intestinal Trials Group
Phase 2 Unknown
NCT04172805 2023-04-12
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05106777 2023-04-12
Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05131386 2023-03-27
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Unknown
NCT02359474 2023-02-28
HyperTET
Ludwig-Maximilians - University of Munich
Phase 2 Unknown
NCT05193188 2023-02-16
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown
NCT04113226 2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2 Unknown
NCT05708391 2023-02-01
Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT05656144 2022-12-19
Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT05602415 2022-11-02
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
Ruijin Hospital
Phase 2 Unknown
NCT03359005 2022-11-01
Irinotecan and Temozolomide for Ewing Sarcoma
Peking University People's Hospital
Phase 2 Unknown
NCT04012827 2022-09-07
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04065152 2022-06-10
KAPVEC
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT05265793 2022-03-04
Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
Fudan University
Phase 2 Unknown
NCT03570437 2022-03-02
COPELIA
University of Manchester
Phase 2 Unknown
NCT05142631 2022-03-02
Fruquintinib in the Treatment of Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown
NCT05224999 2022-02-04
Nivolumab for Recurrent/Metastatic Carcinosarcoma
Yonsei University
Phase 2 Unknown
NCT05193214 2022-01-14
A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2 Unknown
NCT02897479 2021-11-30
A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer
Hutchmed
Phase 2 Unknown
NCT05138146 2021-11-30
A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2 Unknown
NCT02106312 2021-08-04
DOREMY
The Netherlands Cancer Institute
Phase 2 Unknown
NCT04910126 2021-06-02
Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT03623581 2021-03-03
Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226)
Genor Biopharma Co., Ltd.
Phase 2 Unknown
NCT04765228 2021-02-21
Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown
NCT03989596 2021-02-01
SINDIR
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Unknown
NCT03651375 2021-01-22
UN-RESARC
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Unknown
NCT04606108 2020-10-28
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04356872 2020-07-14
The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown
NCT04447274 2020-06-25
A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS
ChineseAMS
Phase 2 Unknown
NCT02968303 2020-06-05
COWBOY
Radboud University Medical Center
Phase 2 Unknown
NCT04351308 2020-05-19
MAPAC
Peking University People's Hospital
Phase 2 Unknown
NCT03268772 2020-04-22
PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS
Fudan University
Phase 2 Unknown
NCT04319874 2020-03-30
Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown
NCT00276783 2020-03-05
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Northwestern University
Phase 2 Unknown
NCT04294511 2020-03-04
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04239443 2020-01-27
Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer
Hunan Cancer Hospital
Phase 2 Unknown